Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Hepaglide 0.25 mg Injection is a weekly subcutaneous,, prescription-based, semaglutide-based medication used to manage type 2 diabetes, obesity, and weight loss. It is a GLP-1 receptor agonist that acts by lowering blood sugar, slowing digestion, and reducing appetite and typically supplied in a prefilled multi-dose pen with needles.
| Strength | 0.25 mg |
| Main Ingredients | Semaglutide |
| Storage | 2–8°C (Cold Chain Logistics) |
| Therapeutic Class | GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist |